We have conducted a daily longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections in two universities, UIUC and NU. We compared viral culture outcomes with nasal and saliva PCR results for up to 15 days and this is what we found. A thread ��— Pamela P. Martinez (@PamelaPMartinez) September 2, 2021
We have conducted a daily longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections in two universities, UIUC and NU. We compared viral culture outcomes with nasal and saliva PCR results for up to 15 days and this is what we found. A thread ��
09-02-2021, 12:04 PM
